BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 12125943)

  • 1. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
    Douglas WS; Poulin Y; Decroix J; Ortonne JP; Mrowietz U; Gulliver W; Krogstad AL; Larsen FG; Iglesias L; Buckley C; Bibby AJ
    Acta Derm Venereol; 2002; 82(2):131-5. PubMed ID: 12125943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.
    Kaufmann R; Bibby AJ; Bissonnette R; Cambazard F; Chu AC; Decroix J; Douglas WS; Lowson D; Mascaro JM; Murphy GM; Stymne B
    Dermatology; 2002; 205(4):389-93. PubMed ID: 12444337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
    Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL
    Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
    Yan R; Jiang S; Wu Y; Gao XH; Chen HD
    Indian J Dermatol Venereol Leprol; 2016; 82(2):135-44. PubMed ID: 26924402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
    Girolomoni G; Vena GA; Ayala F; Cannavò SP; De Pità O; Chimenti S; Peserico A
    G Ital Dermatol Venereol; 2012 Dec; 147(6):609-24. PubMed ID: 23149707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
    Saraceno R; Andreassi L; Ayala F; Bongiorno MR; Giannetti A; Lisi P; Martini P; Peris K; Peserico A; Chimenti S
    J Dermatolog Treat; 2007; 18(6):361-5. PubMed ID: 17934937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
    Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
    Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal maintenance treatment with calcipotriol/betamethasone dipropionate gel in Korean patients with psoriasis vulgaris: a multicentre randomized, controlled clinical trial.
    Lee JH; Park CJ; Kim TY; Choe YB; Kim NI; Song HJ; Youn JI; Youn SW; Choi JH; Kim KJ
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):483-489. PubMed ID: 27723134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
    Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
    Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
    Fenton C; Plosker GL
    Am J Clin Dermatol; 2004; 5(6):463-78. PubMed ID: 15663344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
    Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
    Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
    Claréus BW; Houwing R; Sindrup JH; Wigchert S
    Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Jolliffe D; Peyri J; Svensson A; Toole J; Wozel G
    Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
    van Geel MJ; Mul K; Oostveen AM; van de Kerkhof PC; de Jong EM; Seyger MM
    Br J Dermatol; 2014 Aug; 171(2):363-9. PubMed ID: 24593129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.
    Kim ES; Frampton JE
    Drugs; 2016 Oct; 76(15):1485-1492. PubMed ID: 27663245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.
    Queille-Roussel C; Olesen M; Villumsen J; Lacour JP
    Clin Drug Investig; 2015 Apr; 35(4):239-45. PubMed ID: 25708531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.